Original Research
Accepted on 24 Apr 2025
Trends in hemolytic anemia-related mortality in the United States from 1999-2022
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1560766
Type at least 3 characters
132 articles
Case Report
Published on 24 Apr 2025
Case Report: Teclistamab in the treatment of idiopathic immune thrombocytopenia in patients with multiple myeloma
in Immunobiology and Immunotherapy
Frontiers in Hematology
doi 10.3389/frhem.2025.1547209
- 165 views
Original Research
Accepted on 23 Apr 2025
Down-regulated PTEN and aberrant JAK-STAT Signal Pathway in Essential Thrombocythemia Patients
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1479185
Clinical Trial
Published on 22 Apr 2025
Preliminary clinical activity of TP-0903 in relapsed or refractory acute myeloid leukemia with FLT3-ITD mutations
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1554764
- 235 views
Mini Review
Accepted on 14 Apr 2025
Erythroblast Island Macrophages and Their Surface Markers
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1580621
Review
Published on 14 Apr 2025
Metabolic reprogramming of fetal hematopoietic stem and progenitor cells by maternal obesity
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1575143
- 221 views
Original Research
Accepted on 10 Apr 2025
Disease and treatment burden in patients with leukemia: family members/partner perspective
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1570055
Original Research
Published on 09 Apr 2025
Anemia and its predictors among neonates at Wachemo University teaching hospital, Central Ethiopia: a facility-based cross-sectional study
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1550664
- 291 views
Original Research
Accepted on 07 Apr 2025
Mogamulizumab in combination improves clinical outcomes in relapsed and refractory SĂ©zary syndrome
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1557641
Brief Research Report
Published on 03 Apr 2025
Assessing maternal and perinatal complication incidence in pregnant patients with sickle cell disease: a retrospective analysis of transfusion therapy at a tertiary care hospital
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1549241
- 328 views
Original Research
Published on 21 Mar 2025
Cochrane’s contribution to global health: three decades of progress in sickle cell disease research
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1535100
- 314 views
Review
Published on 21 Mar 2025
Exercise and diet studies among patients living with multiple myeloma: current evidence and considerations of patient preferences
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1550681
- 822 views
Original Research
Published on 17 Mar 2025
HPLC first approach in detecting thalassemia and other common hemoglobinopathies is more cost and time effective
in Red Cells, Iron and Erythropoiesis
Frontiers in Hematology
doi 10.3389/frhem.2025.1461498
- 657 views
Case Report
Published on 04 Mar 2025
Case Report: Triplet combination with pirtobrutinib/venetoclax/rituximab in accelerated phase of chronic lymphocytic leukemia
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1552200
- 643 views
Editorial
Published on 04 Mar 2025
Editorial: Hematopoietic stress in stem cell homeostasis and disease pathogenesis
in Hematopoiesis and Stem Cells
Frontiers in Hematology
doi 10.3389/frhem.2025.1571674
- 356 views
Review
Published on 03 Mar 2025
Abnormalities of primary and secondary hemostasis in multiple myeloma: insights from studies on thrombopoiesis, the coagulation system, and the bone marrow microenvironment
in Blood Cancer
Frontiers in Hematology
doi 10.3389/frhem.2025.1435193
- 648 views